Russia backing for Covid-19 ‘good for India’
NEW DELHI: Russia’s approval of the antiviral drug Avifavir to treat COVID-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists. According to foreign media reports, Avifavir, described by its developers in Russia as perhaps the most promising anti Covid-19 drug in the world, is derived from Favipiravir, foreign media reported. Mumbai-based Glenmark Pharmaceuticals announced last week that Favipiravir is under phase 3 clinical trials - the penultimate stage in drug testing - in India. Stating that Avifavir has shown high efficacy in treating patients with coronavirus during clinical trials, the Russian Direct Investment Fund (RDIF) on Monday said it will deliver 60,000 courses of drug to Russian hospitals in June.
-
Why Ariana Grande Wants A 'tiny Mouse' To Play Her In Biopic? -
Wind Chill Returns With Brutal Cold As Polar Vortex Stalls Over Canada -
Costco $20 Rule Explained As Employee Pay Climbs Across North America -
Strange Incident Happened At Nancy Guthrie's Home On Abduction's 10th Day -
Tumbler Ridge School Lockdown Underway As RCMP Investigate School Shooting -
Britney Spears Quietly Parts Ways With Her Music Catalog: Report -
Princess Diana Bodyguard Suspected ‘she Could Die’: Here’s How -
Teddi Mellencamp Marks Huge Milestone With Emotional Message Amid Cancer -
King Charles Makes It ‘absolutely Clear’ He Wants To Solve Royal Crisis -
Kylie Jenner Looks Back With 'grace' On Early Fame Years: 'Just Being Myself' -
Royal Family Warned To ‘have Answers’ Amid Weak Standing -
Marc Anthony On Why Bad Bunny’s Super Bowl Show Mattered -
Kid Rock Gets Honest About Bad Bunny’s Performance At Super Bowl -
Kylie Jenner Reveals Real Story Behind Her 'The Moment' Casting -
Jaafar Jackson Breaks Silence On Becoming Michael Jackson -
Eva Mendes Admits She Was Jealous Of Ryan Gosling’s CGI ‘girlfriend’ Rocky